Cilostazol and Generalised oedema - a phase IV clinical study of FDA data

Summary:

Generalised oedema is reported as a side effect among people who take Cilostazol (cilostazol), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Aspirin, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Generalised oedema when taking Cilostazol. It is created by eHealthMe based on reports of 7,796 people who have side effects when taking Cilostazol from the FDA, and is updated regularly.

What is Cilostazol?

Cilostazol has active ingredients of cilostazol. It is often used in arteriosclerosis of the extremities. eHealthMe is studying from 7,877 Cilostazol users. Check the latest studies of Cilostazol.

What is Generalised oedema?

Generalised oedema (swelling all over the body) is found to be associated with 1,091 drugs and 1,405 conditions by eHealthMe. Check the latest studies of Generalised oedema.

On Jul, 14, 2026

7,796 people reported to have side effects when taking Cilostazol.
Among them, 29 people (0.37%) have Generalised oedema.

Could Cilostazol cause Generalised oedema?

Among these 29 people:

How long have people been on Cilostazol when they have Generalised oedema? *

What is the gender of people who have Generalised oedema when taking Cilostazol? *

female: 24.14 %
male: 75.86 %

What is the age of people who have Generalised oedema when taking Cilostazol? *

What are other drugs people take besides Cilostazol? *

What are other side effects people have besides Generalised oedema? *

Dyspnea (difficult or laboured breathing): 14 people, 48.28%
Back Pain: 14 people, 48.28%
Oedema Peripheral (superficial swelling): 13 people, 44.83%
Cardiac Failure Congestive: 13 people, 44.83%
Fainting (loss of consciousness and postural tone): 13 people, 44.83%
Nausea (feeling of having an urge to vomit): 12 people, 41.38%
Pneumonia: 12 people, 41.38%
Enlarged Heart: 12 people, 41.38%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 12 people, 41.38%
Depression: 11 people, 37.93%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 12 people, 41.38%
Bone Disorder: 11 people, 37.93%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 3 people, 10.34%
High Blood Pressure: 3 people, 10.34%
Amyloidosis (a tumour within which amyloid is produced): 2 people, 6.90%
Pleural Effusion (water on the lungs): 2 people, 6.90%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 6.90%
Diabetes: 2 people, 6.90%
Atherosclerosis Obliterans (disorder of medium and large arteries of the lower extremity): 1 person, 3.45%
Cardiac Amyloidosis (protein deposition in heart): 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Cilostazol and have Generalised oedema?

- Check whether Generalised oedema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cilostazol:

Cilostazol (7,877 reports)

Browse all side effects of Cilostazol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Generalised oedema:

Generalised oedema (1,091 drugs)

Browse all the conditions that are associated with Generalised oedema:

Generalised oedema (1,405 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cilostazol (the active ingredients of Cilostazol) and Cilostazol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.